mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability

A drawback of the current mRNA-lipid nanoparticle (LNP) COVID-19 vaccines is that they have to be stored at (ultra)low temperatures. Understanding the root cause of the instability of these vaccines may help to rationally improve mRNA-LNP product stability and thereby ease the temperature conditions...

Descripción completa

Detalles Bibliográficos
Autores principales: Schoenmaker, Linde, Witzigmann, Dominik, Kulkarni, Jayesh A., Verbeke, Rein, Kersten, Gideon, Jiskoot, Wim, Crommelin, Daan J.A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier B.V. 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8032477/
https://www.ncbi.nlm.nih.gov/pubmed/33839230
http://dx.doi.org/10.1016/j.ijpharm.2021.120586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8032477/
https://www.ncbi.nlm.nih.gov/pubmed/33839230
http://dx.doi.org/10.1016/j.ijpharm.2021.120586

Ejemplares similares